Immunologic abnormalities associated with chronic fatigue syndrome.
Barker, E, Fujimura, S F, Fadem, M B et al. · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 1994 · DOI
Quick Summary
This study examined immune cells in the blood of ME/CFS patients and compared them to healthy people. Researchers found that ME/CFS patients had normal numbers of immune cells overall, but the cells showed signs of being overactive and tired. Most notably, patients had significantly reduced natural killer cell activity—these are immune cells that normally help fight infections and abnormal cells.
Why It Matters
This study provided early evidence that ME/CFS involves measurable immune dysfunction, particularly NK cell impairment, which helps validate that the illness has a biological basis. Understanding these immune abnormalities has guided subsequent research into whether immune system dysregulation drives ME/CFS symptoms and could inform future therapeutic approaches targeting immune restoration.
Observed Findings
CD8+ T cells in CFS patients showed reduced CD11b expression combined with elevated activation markers (CD38 and HLA-DR)
Many CFS patients displayed increased CD28 expression on CD8+ T cells, suggesting clonal expansion of activated cytotoxic T lymphocytes
Marked decrease in natural killer (NK) cell activity was found in almost all CFS patients compared to healthy controls
Total counts of T cells (CD3+), B cells (CD19+), and NK cells (CD16+, CD56+) were within normal ranges
Monocyte activity and T cell proliferation responses showed no substantial abnormalities
Inferred Conclusions
Immune cell phenotype changes, particularly CD8+ T cell activation, are common in CFS
NK cell dysfunction is a nearly universal finding in CFS and may contribute to immunologic abnormalities
CFS involves selective immune dysfunction rather than global immunosuppression, as some immune functions remain intact
Remaining Questions
What triggers the CD8+ T cell activation and NK cell dysfunction observed in CFS?
Does NK cell impairment precede CFS symptom onset or develop as a consequence of the illness?
What This Study Does Not Prove
This study documents immune cell abnormalities in CFS patients but does not establish whether these changes cause ME/CFS symptoms, result from the illness, or are merely associated with it. It also does not explain what triggers these immune changes or whether correcting them would improve patient outcomes. The cross-sectional design cannot establish temporal relationships or causality.